Danaher Corporation's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Capital-Expenditures" stands at 1.30 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.
Danaher Corporation's third quarter result of 0.292 Billion USD for the item "Capital Expenditures" represents an increase of 17.74 percent compared to it's second quarter result.
Also, Danaher Corporation's third quarter result of 0.292 Billion USD for the item "Capital Expenditures" represents a decrease of -2.01 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Danaher Corporation's third quarter result of 1.30 Billion USD for the item "Capital Expenditures" represents a decrease of -0.46 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.80 percent compared to the value the year prior.
The 1 year change in percent is 1.80.
The 3 year change in percent is 4.67.
The 5 year change in percent is 98.78.
The 10 year change in percent is 148.80.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - Capital Expenditures | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - Capital Expenditures | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - Capital Expenditures | 172,241,486,586.05 |
![]() | Boston Scientific Corp - Capital Expenditures | 144,567,730,176.00 |
![]() | Stryker Corporation - Capital Expenditures | 139,209,850,880.00 |